Search clinical trials for: phase 0

Total 19843 results

National Cancer Institute (NCI)

Completed

A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients

Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

Melanoma

United States
National Cancer Institute (NCI)

Completed

Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis

Stomach Neoplasms | Peritoneal Neoplasms

United States
National Cancer Institute (NCI)

Completed

New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma

Neuroblastoma | Rhabdomyosarcoma | Ewing's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

HIV Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers

Acquired Immunodeficiency Syndrome | HIV Infection

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer

Kidney Neoplasms | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver

Neoplasm Metastasis | Liver Neoplasms

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis

Vasculitis | Wegener's Granulomatosis

United States
National Cancer Institute (NCI)

Completed

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

Lymphoma | Carcinoma, Renal Cell | Cancer | Breast Cancer | Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy

Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

Carcinoma, Transitional Cell | Bladder Neoplasms

United States
National Institute of Neurological Disorders and...

Completed

A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients

Multiple Sclerosis

United States
National Institute of Neurological Disorders and...

Completed

Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia

Friedreich Ataxia

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Lymphoma | Breast Cancer | Neoplasm Metastasis | Ovarian Cancer | Kidney Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Prostatic Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Neoplasm Metastasis | Colorectal Neoplasm | Liver Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia

Hairy Cell Leukemia

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma

Neoplasm Metastasis | Osteosarcoma

United States
National Cancer Institute (NCI)

Completed

Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy

Brain Neoplasms | Neuroblastoma

United States
National Cancer Institute (NCI)

Completed

A Phase II Evaluation of Telesurgery Systems

Laparoscopy

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections

Mycobacterium Avium-Intracellulare Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Trial of Smallpox Vaccine

Healthy

United States
National Cancer Institute (NCI)

Completed

Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis

Carcinoma | Peritoneal Neoplasm

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants

Cutaneous Leishmaniasis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

Herpes Simplex

United States
National Cancer Institute (NCI)

Completed

Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers

Colorectal Neoplasm | Hereditary Nonpolyposis

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma

B Cell Lymphoma

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma

Hypersensitivity | Asthma

United States
National Institute of Diabetes and Digestive and...

Completed

Kidney Transplant for HIV-Infected Patients in Renal Failure

HIV Infection | Chronic Kidney Failure

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

Breast Cancer | Breast Neoplasms

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood

Chronic Granulomatous Disease

United States
National Cancer Institute (NCI)

Completed

A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab

Stomach Neoplasms | Breast Neoplasms | Lung Neoplasms | Pancreatic Neoplasms | Colonic Neoplasms

United States
National Cancer Institute (NCI)

Completed

Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors

Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients

Breast Cancer | Breast Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin

Ovarian Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas

Gastrointestinal Neoplasms | Pancreatic Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease

Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection

HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy

Glioma | Sarcoma

United States
National Cancer Institute (NCI)

Completed

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Mycoses | Candidiasis | Fungemia | Aspergillosis

United States
National Cancer Institute (NCI)

Completed

Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR

Leukoplakia | Periodontal Disease

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Melanoma | Lymphoma | Renal Cell Carcinoma | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

Sepsis | Hematologic Diseases | Breast Neoplasms | Neutropenia | Fever

United States
National Eye Institute (NEI)

Completed

Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration

Macular Degeneration | Choroidal Neovascularization

United States
National Institute of Diabetes and Digestive and...

Completed

A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

Sickle Cell Anemia | Hemoglobin SC Disease

United States
National Cancer Institute (NCI)

Completed

Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials

Neoplasm

United States

3

Subscribe